Latest news
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Sun, 09 Aug 2026 21:35:26 GMTPriovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) - finance.yahoo.comfinance.yahoo.com · Thu, 06 Aug 2026 11:00:00 GMT